Annvrridhhi Ventures Limited

Consumer Defensive — Food Distribution · BSE

₹10.27+₹0.09 (+0.88%)

DalalBaazaar Score

50 / 100

🟡 Moderate

Verdict

CAUTION

Risk

High

Driven by negative free cash flow, micro-cap size, which brings thin liquidity, falling profits.

In simple words: The business is earning a fairly low return on the money invested in it, though profits are falling even as sales grow. Cash generation is currently the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:09 pm

Caution warranted. Multiple fundamental metrics — flagged in red below — point to either valuation stretch, leverage risk, or weakening profitability. This doesn't mean avoid the stock outright, but it does mean the burden of proof is on the growth story to justify the current price.

Understanding the Business

Company site ↗

The 60-second version of Annvrridhhi Ventures Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Annvrridhhi Ventures Limited trades in agro-commodity business in India. The company was formerly known as J. Taparia Projects Limited and changed its name to Annvrridhhi Ventures Limited in November 2024.

IndustryFood Distribution

SectorConsumer Defensive

Annual revenue₹100 Cr

How does it make money?

Turns over ₹100 Cr a year. Of every ₹100 of sales, about ₹1 reaches shareholders as profit, with ₹1 left at the operating level before interest, tax and depreciation.

EBITDA margin1.1%

Net margin0.7%

Who are its competitors?

The closest listed comparisons in its industry are HINDUSTAN UNILEVER LTD., ITC LTD, NESTLE INDIA LIMITED, BRITANNIA INDUSTRIES LTD. These are the companies its valuation and returns are measured against elsewhere in this report.

HINDUSTAN UNILEVER LTD.P/E 42.5x · ROE 21.5%

ITC LTDP/E 16.6x · ROE 27.4%

NESTLE INDIA LIMITEDP/E 59.8x · ROE 79.9%

BRITANNIA INDUSTRIES LTDP/E 44.1x · ROE 51.0%

What is its competitive advantage?Little sign of one

Returns on capital of 5.6% are at or below what the capital likely costs. That is the financial pattern of a business competing largely on price, where advantage has to come from execution rather than position.

ROCE5.6%

ROE3.9%

Peer median ROE51.0%

What has been driving growth?

Growth has come mainly from selling more, rather than from keeping more of each sale. Over 3 years revenue moved +77376% while net margin moved -74% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+77376%

Margin effect-74%

DalalBaazaar Score

50/ 100

Moderate

Weighted across six categories. Every point is explained below.

✗ Micro Cap: thinner liquidity and sharper drawdowns are normal
✗ Profits have swung sharply from year to year — earnings are hard to forecast
✗ Negative free cash flow means dependence on external funding

Quality vs. Valuation

Company Quality

50/ 100

Average

How good the business is, ignoring the share price entirely.

Valuation

72/ 100

Cheap

What you are being asked to pay, ignoring how good the business is.

A reasonable business at a reasonable price — neither the quality nor the valuation stands out in either direction.

Historical Valuation

Current P/E

26.3x

3Y Median

8522.6x

40 monthly readings · mean 9470.5x · range 24.3x–39167.6x

Sector Median

43.3x

median of 4 sector peers

🟢Current valuation is approximately 100% below its 3y median of 8522.6x. Cheaper than its own history, which is worth a reason too: the market may be pricing in something the backward-looking numbers do not show.

🟢Against its sector it trades 39% below the peer median of 43.3x.

vs. its own history

Cheap

8522.6x median over 40 months · -100%

vs. sector peers

Cheap

43.3x median of 4 peers · -39%

vs. generic bands

Fair

15x–35x

P/E (Trailing)

26.3x

P/B

—

EV/EBITDA

55.6x

PEG

0.05

Dividend Yield

None

What's Good / What's Bad

🟢 What's Going Well3

Return on equity is rising
ROE has improved from 0.0% to 3.9%.
Return on capital is rising
ROCE has improved from 0.0% to 5.6%.
Valuation below its historical average
At 26.3x the stock trades 100% below its own median of 8522.6x.

🔴 What Needs Attention3

Margins are compressing
EBITDA margin has slipped from 9.8% to 1.1% over 3 years.
Debt is rising
Total debt is up 8003% over 3 years — worth checking what it funded.
Free cash flow is negative
The business is not currently covering its capital spending from operations.

Red Flags

5 items require attention · 3 high · 2 watch

🔴Debt has risen sharplyFinancial
Total debt is up 8003% over 3 years, from ₹0 Cr to ₹13 Cr.
🔴Free cash flow negative for 3 yearsFinancial
The business has not covered its capital spending from operations for several years running, which has to be funded externally.
🔴Significant margin compressionFinancial
EBITDA margin has fallen 8.7 points, from 9.8% to 1.1%.
🟡Interest coverage is deterioratingFinancial
Cover has fallen from 11.3x to 3.3x.
🟡Shareholders have been dilutedOwnership
Shares outstanding are up 170% over 3 years — each existing share owns a smaller slice of the company.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Priced below its own history
The stock trades 100% below its own median multiple. If the business performs as it has and simply re-rates back to normal, that gap is return on its own.
Cheaper than its peers
It trades 39% below the sector median. Either the market sees a problem the numbers do not show, or the discount closes.

🔴 Bear CaseWhat could go wrong?

Margins are being competed away
EBITDA margin has fallen from 9.8% to 1.1%. If the trend continues, profit falls even on flat sales — and margin decline rarely reverses quickly.
The debt load needs earnings to hold up
Debt is 11.9x EBITDA. At that level a downturn in earnings turns a manageable balance sheet into a refinancing problem, and lenders get paid before shareholders.
Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.
Several serious flags at once
3 high-severity checks triggered. Individually each has an explanation; together they raise the chance that something structural is wrong rather than a one-off.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Revenue growth stays above 614% a year✓ 818.5% CAGR
Latest reported year was 49.1%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
2EBITDA margin holds above -1%✓ 1.1%
Two points below today's level — enough room for noise, tight enough to catch real compression.
3Debt / EBITDA falls below 3x✗ 11.9x
Already stretched, so this is a reduction target rather than a level to hold. Around 3x is where lenders typically start attaching conditions.
4Free cash flow remains positive✗ -₹18 Cr
Profit that never becomes cash eventually stops being profit.
5Interest cover stays above 3x✓ 3.3x
How much operating profit can fall before interest stops being comfortably covered.

Investment Checklist

6 / 11 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✗ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✓ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✗ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✓ Short-term technical trend isn't bearish

Price history

Quick Metrics

2 good · 5 neutral · 4 weak

Market Cap

₹47 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

26.3x

Fair

Fairly valued against the generic band

P/B Ratio

Not available

No data

Source didn't return this field

EPS (TTM)

₹0.39

Profitable

Profitable on a per-share basis

ROE

3.9%

Weak

Weak capital efficiency

ROCE

5.6%

Weak

Low return on total capital employed

Debt/Equity

0.69x

Moderate

Moderate leverage

Revenue Growth (YoY)

49.1%

Healthy

Healthy top-line growth

Profit Growth (YoY)

-1.8%

Falling

Profits are shrinking

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

-₹18 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

CMP

₹10.27

Operating Margin

0.0%

Weak

Thin margins leave little room for error

Net Margin

0.0%

Weak

Very little revenue reaches the bottom line

Current Ratio

1.43

Comfortable

Healthy short-term liquidity

52W Range Position

32%

Mid-range

Technical Snapshot

SMA 20 / SMA 50

11.0 / 10.2

Bullish alignment (short > long)

Price vs SMA 200

Above

Long-term uptrend

RSI (14)

32.3

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹0 Cr	₹3 Cr	₹67 Cr	₹100 Cr	+818.5%
EBITDA	₹0 Cr	-₹0 Cr	₹1 Cr	₹1 Cr	+340.3%
EBITDA Margin	9.8%	-4.8%	1.4%	1.1%	—
PAT (Net Profit)	₹0 Cr	-₹6 Cr	₹1 Cr	₹1 Cr	+485.8%
EPS	₹0	₹-3.73	₹0.38	₹0.39	+499.1%
ROE	0.0%	-65.8%	7.1%	3.9%	—
ROCE	0.0%	-65.8%	7.6%	5.6%	—
Total Debt	₹0 Cr	—	₹2 Cr	₹13 Cr	+332.7%
Free Cash Flow	₹0 Cr	-₹1 Cr	-₹1 Cr	-₹18 Cr	—

🟢 Revenue has grown at 818.5% a year over 3 years.

🟢 EBITDA has grown at 340.3% a year over 3 years.

🔴 EBITDA Margin has fallen from 9.8% to 1.1% over 3 years (-8.7 pts).

🟢 PAT (Net Profit) has grown at 485.8% a year over 3 years.

🟢 EPS has grown at 499.1% a year over 3 years.

🟢 ROE has risen from 0.0% to 3.9% over 3 years (+3.9 pts).

🟢 ROCE has risen from 0.0% to 5.6% over 3 years (+5.5 pts).

🔴 Total Debt has grown at 332.7% a year over 3 years.

🔴 Free Cash Flow has turned negative, from ₹0 Cr to -₹18 Cr.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹43 Cr

Total Liabilities

₹24 Cr

Total Debt

₹13 Cr

Cash & Equivalents

₹0 Cr

Operating Cash Flow

-₹18 Cr

Capex

-₹0 Cr

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

37.0%

Peer Comparison

Company	P/E	ROE
HINDUSTAN UNILEVER LTD.	42.5x	21.5%
ITC LTD	16.6x	27.4%
NESTLE INDIA LIMITED	59.8x	79.9%
BRITANNIA INDUSTRIES LTD	44.1x	51.0%

Recent News

2 mixed4 general

Annvrridhhi Ventures closes trading window for Q2FY27 results

scanx.trade, 27 SeptResults

🟡Mixed / dependsA results event. The figures on this page update once the new statements reach the data feed, which usually lags the announcement.

Annvrridhhi Ventures Ltd. (ANVRDHI) Share Price Surges 8.8% Today

Univest, 28 JulPrice move

🟡Mixed / dependsA price move, which is not by itself a change in the business. Worth finding the cause before reading it as either good or bad.

Annvrridhhi Ventures Ltd Partly Paidup Share Price

Business Today, 13 Jul

Annvrridhhi Ventures fixes record date for ₹4 call on rights shares

scanx.trade, 06 Jul

ANNVRRIDHHI VENTURES LIMITED Share Price - Live ANVRDHI Stock Price & Chart

Upstox, 21 Oct

Annvrridhhi Ventures approves all five resolutions at 46th AGM

scanx.trade, 30 Sept

Watch Items

Cross-check against the company's latest quarterly filing / investor presentation before acting.
1 metric couldn't be retrieved for this stock — this is more common for smaller or thinly-covered listings.

DalalBaazaar Thesis

🔴Business QualityWeak7.5/20

🟡Financial HealthAdequate9.8/20

🟡GrowthModest12.9/20

🟡ProfitabilityModerate7.1/15

🟢ValuationAttractive9.9/15

🔴RiskHigh2.5/10

Unremarkable in both directions

A reasonable business at a reasonable price. Nothing here is alarming and nothing is compelling, which usually means the decision rests on things this data cannot see — the industry's direction, management's intent, and what else is available to you. 3 high-severity red flags sit above this conclusion and should be read first.

This thesis breaks if

✓Revenue growth stays above 614% a year818.5% CAGR
✓EBITDA margin holds above -1%1.1%
✗Debt / EBITDA falls below 3x11.9x
✗Free cash flow remains positive-₹18 Cr
✓Interest cover stays above 3x3.3x